NEW YORK AND NAPLES, FL – September 15, 2025 – The Cardiovascular Research Foundation® (CRF®) and Jon DeHaan Foundation today announced the launch of the TCT AI Lab, a groundbreaking new program debuting at TCT® 2025, October 25–28 at the Moscone Center in San Francisco.
The TCT AI Lab is a first-of-its-kind destination dedicated to integrating artificial intelligence into clinical practice. Over three intensive days, clinicians will progress from the fundamentals of AI to hands-on clinical applications – guided by leading innovators at the forefront of digital medicine.
“AI is transforming medicine, and cardiology is no exception,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF®. “The TCT AI Lab will give clinicians not just a window into this future, but the skills and confidence to lead it – advancing precision, efficiency, and better outcomes for patients worldwide.”
This transformative initiative is made possible through a generous grant from the Jon DeHaan Foundation, whose longstanding commitment to innovation continues to shape the future of cardiovascular care.
“The Jon DeHaan Foundation is proud to support the TCT AI Lab, which represents a bold step forward in equipping clinicians to embrace AI,” said Robert Schwartz, MD, President of the Jon DeHaan Foundation. “We believe that empowering physicians through education and training is essential to driving innovation and improving patient outcomes.”
“We are deeply grateful to the Jon DeHaan Foundation for their visionary partnership. Together, we are helping clinicians not just keep pace with change, but lead the transformation of cardiovascular care,” Dr. Granada added.
Inside the TCT AI Lab
Powered by CRF® & the Jon DeHaan Foundation
Sunday, October 26 – Tuesday, October 28
Participants will take part in an immersive curriculum combining lectures, tutorials, and interactive demonstrations:
- AI Fundamentals for Clinicians
Build a strong foundation in AI concepts, understand algorithmic architecture, and gain the confidence to evaluate and apply AI tools. - Real-World Applications
Explore how AI is already revolutionizing cardiovascular care from ECG analysis and coronary artery disease diagnosis to imaging interpretation and patient reporting. - Hands-On Tutorials
Engage directly with the platforms and technologies driving AI innovation in clinical settings.
More information is available at: https://www.tctconference.com/tct-ai-lab.
About CRF® and TCT®
The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF®’s centers of excellence include the CRF® Skirball Center for Innovation, CRF® Clinical Trials Center, CRF® Center for Education, CRF® Digital, TCTMD®, and Structural Heart: The Journal of the Heart Team.
Transcatheter Cardiovascular Therapeutics® (TCT®) is the annual scientific symposium of CRF® and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Anchored in a legacy spanning over three decades, TCT® is a world-class educational experience featuring disruptive innovation, scientific breakthroughs, expert-led tutorials, hands-on training, and ample opportunities for networking and collaboration.
For more information, visit www.crf.org and www.tctconference.com.
About the Jon DeHaan Foundation
The Jon Holden DeHaan Foundation, DBA the Jon DeHaan Foundation, provides grants and funding to individuals and companies focused on advancing treatments in cardiovascular medicine. Since 2018, the Foundation has recognized outstanding med-tech innovations with its Award for Innovation in Cardiology. This award provides funding to those who exemplify excellence and whose technological developments will have a significant impact on cardiovascular disease prevention, diagnosis, treatment, or rehabilitation. This program is open to academic and health professionals, as well as engineers, business professionals, and med-tech companies. Applicants must have the intent to commercialize their research.
For more information, visit www.jondehaanfoundation.org.
###